|
Unomedical hereby submits this initial report as part of its complaint remediation activities conducted under a capa 2356421 and capa 2566479 in accordance with the fda action plan, which incorporates qp-ic-2026-0020 (ic retrospective complaint review) and qp-ic-2026-0024 (ic retrospective mdr review).This submission includes a retrospective reassessment of previously evaluated complaints.Unomedical is providing this supplemental information in accordance with the reporting requirements set forth in 21 cfr part 803.Any fields left blank indicate that the information is unknown, unavailable, or remains unchanged e1: patient city: (b)(6) patient country: united states.Additional information - this medical device report (mdr) is being submitted to include the below: h6: investigation results under type of investigation, investigation findings, investigation conclusions h11: investigation summary additional information was requested to support the investigation; however, a lot number or any product specific information was not provided.No device, device components, or other visual or physical evidence was made available for evaluation.Consequently, visual inspection, retain-sample testing, or the assessment of potential product performance issues, component integrity, or manufacturing defects could not be performed.In response to the complaint and due to the absence of a specific lot number, a high-level review of manufacturing controls for the minimed quick set product family was conducted to document the routine controls used to detect potential defects at the product family level.The review identified the following controls in use for the product family, including 100% functional testing during final assembly (eg., leak and flow tests) 100% visual inspections during packaging sampling verification under acceptable quality limit (aql) 0.65, including visual and functional tests such as: burst and peel tests connector tension tests dimensional measurements.Corrective and preventive action (capa) based on the investigation, no further action is required.The record will be closed and monitored through tracking and trending per work instructions (monthly trips and alerts).Complaint investigation ¿ conclusion based on the limited information available, the investigation was completed, and no product malfunction was alleged or identified.The complaint could not be confirmed due to insufficient information, and the record is being closed based on the event description and the information provided in the complaint.Based on the available information, this event is deemed to be death.To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number reporting site: 8021545 manufacturing site: 3003442380.
|